Patent · US Active

Soluble hybrid Fcγ receptors and related methods

US8658766B2 · kind B2 · utility

2Cited by
0References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 29, 2009
Grant dateFeb 25, 2014
Priority date
Expiry dateJul 23, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are soluble hybrid Fcγ receptor (FcγR) polypeptide compositions and related methods of using such polypeptides to treat IgG-mediated and immune complex-mediated inflammation. Also disclosed are related compositions and methods for producing the soluble hybrid FcγR polypeptides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.